| 7.06 0 (0%) | 04-29 14:48 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 10.58 | 1-year : | 12.67 |
| Resists | First : | 9.06 | Second : | 10.85 |
| Pivot price | 7.28  |
|||
| Supports | First : | 6.17 | Second : | 5.13 |
| MAs | MA(5) : | 7.13  |
MA(20) : | 7.74 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | 0 | Signal : | 0 |
| %K %D | K(14,3) : | 33.7 |
D(3) : | 31.9 |
| RSI | RSI(14): 36.6 |
|||
| 52-week | High : | 10.85 | Low : | 6.17 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ AUNA ] has closed above bottom band by 33.5%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 7.32 - 7.37 | 7.37 - 7.41 |
| Low: | 6.93 - 6.97 | 6.97 - 7.01 |
| Close: | 6.99 - 7.07 | 7.07 - 7.13 |
Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.
Tue, 23 Apr 2024
HSBC starts Auna stock with Buy rating citing growth prospects By Investing.com - Investing.com
Tue, 23 Apr 2024
HSBC starts Auna at buy, cites profitable business model (NYSE:AUNA) - Seeking Alpha
Tue, 16 Apr 2024
Citi sets Auna SA stock at buy rating - Investing.com
Fri, 29 Mar 2024
Stibbe assists AUNA S.A. - Stibbe
Fri, 22 Mar 2024
Auna Raises US$360 Million in Gross Proceeds via NYSE IPO, Marking Its Debut in the International Equity Markets - Yahoo Finance
Fri, 22 Mar 2024
Auna Stock Falls After Latin America-Focused Health Chain's IPO Disappoints - Bloomberg
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 30 (M) |
| Shares Float | 16 (M) |
| Held by Insiders | 8 (%) |
| Held by Institutions | 6.1 (%) |
| Shares Short | 150 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | -6.6 % |
| Operating Margin | 14.5 % |
| Return on Assets (ttm) | 5 % |
| Return on Equity (ttm) | -12.9 % |
| Qtrly Rev. Growth | 26.8 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 129.33 |
| EBITDA (p.s.) | 25.68 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 582 (M) |
| Levered Free Cash Flow | 330 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0.05 |
| Price to Cash Flow | 0.36 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|